Cargando…
Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India
Background Patients with major depressive disorder have varying response rates to treatment. Multiple factors such as non-adherence, comorbidity, chronic stressors, and biological factors may be responsible for this variation. Inflammatory (pro and anti) markers have been well studied as a cause for...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481369/ https://www.ncbi.nlm.nih.gov/pubmed/37680396 http://dx.doi.org/10.7759/cureus.43059 |
_version_ | 1785101961415098368 |
---|---|
author | Mandal, Sucharita Spoorthy, Mamidipalli Sai Godi, Sangha Mitra Nanda, Rachita Mukherjee, Bhaskar Mishra, Nihar Ranjan |
author_facet | Mandal, Sucharita Spoorthy, Mamidipalli Sai Godi, Sangha Mitra Nanda, Rachita Mukherjee, Bhaskar Mishra, Nihar Ranjan |
author_sort | Mandal, Sucharita |
collection | PubMed |
description | Background Patients with major depressive disorder have varying response rates to treatment. Multiple factors such as non-adherence, comorbidity, chronic stressors, and biological factors may be responsible for this variation. Inflammatory (pro and anti) markers have been well studied as a cause for depression, predisposing factors, and a consequence of depression. Among these, interleukins (ILs), interferons, C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-α) have been studied repeatedly. We conducted a pilot study to assess the levels of these inflammatory markers in patients with major depressive disorder. The specific objectives of this study were to compare and correlate changes in pro- and anti-inflammatory markers throughout different phases of depression, including pretreatment and posttreatment periods, and to evaluate the pattern of pro- and anti-inflammatory markers in patients who experienced remission or showed a positive response to treatment. Methodology This was a prospective, clinic-based, cohort study done for a period of one and a half years. Patients aged 18-65 years with depressive disorder per the International Classification of Diseases Tenth Edition and who scored more than 7 on the Hamilton Depression Rating Scale were included in this study. A total of 81 patients were recruited who were followed up till eight weeks after inclusion. A total of 31 patients completed the eight weeks of follow-up. Levels of IL-10 and TNF-α were assessed at baseline, two weeks, four weeks, and eight weeks of follow-up. Results This study tried to compare the levels of pro- and anti-inflammatory markers across pretreatment and various posttreatment phases of depression. Results showed that the levels of pro-inflammatory cytokine TNF-α increased from baseline till eight weeks of follow-up, and levels of IL-10 decreased from baseline till eight weeks of follow-up. However, these changes were not statistically significant. Conclusions This study supports the hypothesis that inflammatory markers can be trait markers of depression rather than the consequence or result. |
format | Online Article Text |
id | pubmed-10481369 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-104813692023-09-07 Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India Mandal, Sucharita Spoorthy, Mamidipalli Sai Godi, Sangha Mitra Nanda, Rachita Mukherjee, Bhaskar Mishra, Nihar Ranjan Cureus Psychiatry Background Patients with major depressive disorder have varying response rates to treatment. Multiple factors such as non-adherence, comorbidity, chronic stressors, and biological factors may be responsible for this variation. Inflammatory (pro and anti) markers have been well studied as a cause for depression, predisposing factors, and a consequence of depression. Among these, interleukins (ILs), interferons, C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-α) have been studied repeatedly. We conducted a pilot study to assess the levels of these inflammatory markers in patients with major depressive disorder. The specific objectives of this study were to compare and correlate changes in pro- and anti-inflammatory markers throughout different phases of depression, including pretreatment and posttreatment periods, and to evaluate the pattern of pro- and anti-inflammatory markers in patients who experienced remission or showed a positive response to treatment. Methodology This was a prospective, clinic-based, cohort study done for a period of one and a half years. Patients aged 18-65 years with depressive disorder per the International Classification of Diseases Tenth Edition and who scored more than 7 on the Hamilton Depression Rating Scale were included in this study. A total of 81 patients were recruited who were followed up till eight weeks after inclusion. A total of 31 patients completed the eight weeks of follow-up. Levels of IL-10 and TNF-α were assessed at baseline, two weeks, four weeks, and eight weeks of follow-up. Results This study tried to compare the levels of pro- and anti-inflammatory markers across pretreatment and various posttreatment phases of depression. Results showed that the levels of pro-inflammatory cytokine TNF-α increased from baseline till eight weeks of follow-up, and levels of IL-10 decreased from baseline till eight weeks of follow-up. However, these changes were not statistically significant. Conclusions This study supports the hypothesis that inflammatory markers can be trait markers of depression rather than the consequence or result. Cureus 2023-08-07 /pmc/articles/PMC10481369/ /pubmed/37680396 http://dx.doi.org/10.7759/cureus.43059 Text en Copyright © 2023, Mandal et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Psychiatry Mandal, Sucharita Spoorthy, Mamidipalli Sai Godi, Sangha Mitra Nanda, Rachita Mukherjee, Bhaskar Mishra, Nihar Ranjan Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India |
title | Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India |
title_full | Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India |
title_fullStr | Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India |
title_full_unstemmed | Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India |
title_short | Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India |
title_sort | inflammatory markers in patients with major depressive disorder: a prospective, clinic-based, cohort study from india |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481369/ https://www.ncbi.nlm.nih.gov/pubmed/37680396 http://dx.doi.org/10.7759/cureus.43059 |
work_keys_str_mv | AT mandalsucharita inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia AT spoorthymamidipallisai inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia AT godisanghamitra inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia AT nandarachita inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia AT mukherjeebhaskar inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia AT mishraniharranjan inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia |